Answers are grounded in this paper and cite their sources.
Regorafenib may enhance antitumor immunity through modulation of macrophage polarization, independent of its anti-angiogenic effects. Optimization of regorafenib dosage for rational design of combination therapy regimen may improve the therapeutic index in the clinic.
No takes yet. Share an insight, caveat, or question.
Ou et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: